In Situ Forming Formulation: Development, Evaluation, and Optimization Using 33 Factorial Design

被引:44
作者
Nagarwal, Ramesh C. [2 ]
Srinatha, A. [1 ]
Pandit, Jayanta K. [2 ]
机构
[1] Natl Coll Pharm, Dept Pharmaceut, Shimoga 577201, India
[2] Banaras Hindu Univ, Inst Technol, Dept Pharmaceut, Varanasi 221005, Uttar Pradesh, India
来源
AAPS PHARMSCITECH | 2009年 / 10卷 / 03期
关键词
alginate; diffusion; factorial design; in situ forming; metformin; DRUG-RELEASE; MATRIX TABLETS; DELIVERY; GELLAN; DISSOLUTION; GELATION; PELLETS; PH;
D O I
10.1208/s12249-009-9285-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present investigation concerns with the development and optimization of an in situ forming formulation using 3(3) full factorial design experimentation. Metformin, an antidiabetic drug with upper part of gastrointestinal tract as absorption window was used as a model drug. The formulations were designed with an objective to retain in stomach for an extended time period. The effect of three independent factors-concentrations of sodium alginate (X (1)), gellan gum (X (2)), and metformin (X (3)) on in vitro drug release were used to characterize and optimize the formulation. Five dependent variables-release exponent (Y (1)), dissolution efficiency (Y (2)), drug release at 30 min (Y (3)), 210 min (Y (4)), and 480 min (Y (5)) were considered as optimization factors. The data were statistically analyzed using ANOVA, and a p < 0.05 was considered statistically significant. Three dimensional surface response plots were drawn to evaluate the interaction of independent variables on the chosen dependent variables. Of the prepared 27 formulations, the responses exhibited by batch F17 containing medium level sodium alginate (X (1)), low level gellan (X (2)), and medium level metformin (X (3)) were similar to the predicted responses.
引用
收藏
页码:977 / 984
页数:8
相关论文
共 30 条
[1]   Optimisation of floating matrix tablets and evaluation of their gastric residence time [J].
Baumgartner, S ;
Kristl, J ;
Vrecer, F ;
Vodopivec, P ;
Zorko, B .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 195 (1-2) :125-135
[2]   Robustness testing, using experimental design, of a flow-through dissolution method for a product where the actives have markedly differing solubility properties [J].
Bloomfield, MS ;
Butler, WC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 206 (1-2) :55-61
[3]  
Bolton S., 1990, PHARM STAT PRACTICAL
[4]   THE INFLUENCE OF CALCIUM-IONS, ACETATE AND L-GLYCERATE GROUPS ON THE GELLAN DOUBLE-HELIX [J].
CHANDRASEKARAN, R ;
THAILAMBAL, VG .
CARBOHYDRATE POLYMERS, 1990, 12 (04) :431-442
[5]   Preparation of alginate beads for floating drug delivery system:: effects of CO2 gas-forming agents [J].
Choi, BY ;
Park, HJ ;
Hwang, SJ ;
Park, JB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 239 (1-2) :81-91
[6]  
Crescenzi V., 1990, Novel biodegradable microbial polymers, P227
[7]   Study of formulation variables influencing the drug release rate from matrix tablets by experimental design [J].
Furlanetto, S ;
Cirri, M ;
Maestrelli, F ;
Corti, G ;
Mura, P .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 62 (01) :77-84
[8]   BIOLOGICAL INTERACTIONS BETWEEN POLYSACCHARIDES AND DIVALENT CATIONS - EGG-BOX MODEL [J].
GRANT, GT ;
MORRIS, ER ;
REES, DA ;
SMITH, PJC ;
THOM, D .
FEBS LETTERS, 1973, 32 (01) :195-198
[9]   GELATION OF GELLAN GUM [J].
GRASDALEN, H ;
SMIDSROD, O .
CARBOHYDRATE POLYMERS, 1987, 7 (05) :371-393